|
|
Volumn 45, Issue 8, 2002, Pages 675-686
|
|
Kidney uptake of 186/188Re(V)-DMSA is significantly reduced when the reducing agent is changed from stannous ion to metabisulfite
a
a
a
a
a
a
|
|
Author keywords
186Re(V) DMSA; 188Re(V) DMSA; Medullary carcinoma; Rhenium 188; Tumor therapy
|
|
Indexed keywords
BONE;
CELL CULTURE;
CELLS;
SODIUM COMPOUNDS;
TIN COMPOUNDS;
TUMORS;
186RE(V)-DMSA;
188RE(V)-DMSA;
CELL UPTAKE;
DIFFERENT SOLVENTS;
MEDULLARY CARCINOMA;
METABISULFITE;
REDUCTANTS;
RHENIA 188;
STANNOUS IONS;
TUMOR THERAPY;
CHLORINE COMPOUNDS;
ACETONE;
ACETONITRILE;
BISULFITE;
REDUCING AGENT;
RHENIUM 186;
RHENIUM 188;
SODIUM CHLORIDE;
SODIUM THIOSULFATE;
SOLVENT;
STANNOUS CHLORIDE;
SUCCIMER;
TECHNETIUM 99M;
TIN;
WATER;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BONE;
CANCER RADIOTHERAPY;
COMPLEX FORMATION;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG RETENTION;
DRUG UPTAKE;
EHRLICH ASCITES TUMOR CELL;
IN VITRO STUDY;
KIDNEY;
MALE;
MOUSE;
NONHUMAN;
REDUCTION;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
THIN LAYER CHROMATOGRAPHY;
THYROID MEDULLARY CARCINOMA;
|
|
EID: 0036322570
PISSN: 03624803
EISSN: None
Source Type: Journal
DOI: 10.1002/jlcr.598 Document Type: Article |
|
Times cited : (6)
|
|
References (24)
|
